5AM Partners V, LLC (CIK 1791889) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-10). Recent activity: Sell TRDA (10,494 shares), Sell TRDA (52,317 shares), Sell TRDA (114,756 shares), Sell TRDA (1,718 shares), Sell TRDA (200,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | Entrada Therapeutics, Inc. (TRDA) | 10% Owner | Sell | 10,494 | $73,458 |
| 2026-08-10 | Entrada Therapeutics, Inc. (TRDA) | 10% Owner | Sell | 52,317 | $358,371 |
| 2026-08-03 | Entrada Therapeutics, Inc. (TRDA) | 10% Owner | Sell | 114,756 | $795,259 |
| 2026-08-03 | Entrada Therapeutics, Inc. (TRDA) | 10% Owner | Sell | 1,718 | $11,768 |
| 2025-11-18 | Entrada Therapeutics, Inc. (TRDA) | Insider | Sell | 200,000 | $1.8M |
| 2025-07-11 | Entrada Therapeutics, Inc. (TRDA) | Insider | Sell | 20,065 | $150,488 |
| 2025-07-11 | Entrada Therapeutics, Inc. (TRDA) | Insider | Sell | 6,935 | $52,012 |
| 2025-07-01 | Entrada Therapeutics, Inc. (TRDA) | Insider | Sell | 55,735 | $385,129 |
| 2025-07-01 | Entrada Therapeutics, Inc. (TRDA) | Insider | Sell | 19,265 | $133,121 |
| 2025-07-01 | Entrada Therapeutics, Inc. (TRDA) | Insider | Sell | 18,578 | $126,516 |
| 2025-07-01 | Entrada Therapeutics, Inc. (TRDA) | Insider | Sell | 6,422 | $43,734 |
| 2025-07-01 | Entrada Therapeutics, Inc. (TRDA) | Insider | Sell | 18,578 | $132,275 |
| 2025-07-01 | Entrada Therapeutics, Inc. (TRDA) | Insider | Sell | 6,422 | $45,725 |
Source: SEC Form 4 filings · as of 2026-08-10